Malignant tumors often highly express programmed death-ligand 1 (PD-L1) as an immunosuppressive molecule targeting PD-1 on T cells, causing T cell exhaustion and reducing the T cells’ tumor-killing ability [27]. This evidence concerns the gene CD274 and cancer.